Conduit Pharmaceuticals (CDT) News Today → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free CDT Stock Alerts $3.17 +0.07 (+2.26%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineConduit Pharmaceuticals Inc. (NASDAQ:CDT) Sees Significant Decrease in Short Interestmarketbeat.com - April 12 at 8:36 PMConduit Pharmaceuticals Inc. (NASDAQ:CDT) Short Interest Up 12.8% in Marchmarketbeat.com - April 1 at 3:16 AMConduit Pharmaceuticals Adds Key Leadership Positionsfinance.yahoo.com - March 19 at 2:06 PMConduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officerglobenewswire.com - March 19 at 7:00 AMShort Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Decreases By 39.1%marketbeat.com - March 14 at 8:44 PMConduit Pharmaceuticals Opens New Laboratory in UKfinance.yahoo.com - March 11 at 6:13 PMConduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hubfinance.yahoo.com - March 11 at 7:45 AMConduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hubglobenewswire.com - March 11 at 7:00 AMShort Interest in Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Declines By 13.2%marketbeat.com - March 3 at 5:57 PMConduit Pharmaceuticals: Stellar Management Team, New Business Modelseekingalpha.com - February 28 at 12:13 AMConduit Pharmaceuticals (NASDAQ:CDT) Trading 6.8% Higher marketbeat.com - February 23 at 3:49 AMConduit Pharmaceuticals Inc. (CDT)sg.finance.yahoo.com - February 15 at 7:09 AMConduit Pharmaceuticals Inc. (CDTTW)uk.finance.yahoo.com - February 13 at 8:56 AMConduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - January 31 at 10:26 AMmarketbeat.com - December 13 at 11:18 AMmarketbeat.com - December 8 at 10:55 AMmarketbeat.com - December 8 at 10:11 AMConduit Pharmaceuticals Inc.wsj.com - December 6 at 5:58 AMmarketbeat.com - November 30 at 9:56 AMmarketbeat.com - November 29 at 3:32 PMmarketbeat.com - November 29 at 10:17 AMConduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conferencefinance.yahoo.com - November 2 at 9:39 AMKXIN and ICU among pre-market losersmsn.com - October 31 at 9:20 AMCDT Conduit Pharmaceuticals Inc.seekingalpha.com - October 28 at 11:39 PMConduit Pharmaceuticals Inc (CDT)uk.investing.com - October 24 at 8:47 AMConduit Pharma CEO Tapolczay on Biopharma Differentiation, Pipelinefinance.yahoo.com - October 11 at 11:54 AMConduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656finance.yahoo.com - October 11 at 11:54 AMmarketbeat.com - October 4 at 10:34 AMmarketbeat.com - October 4 at 10:27 AMmarketbeat.com - October 4 at 10:19 AMmarketbeat.com - October 4 at 9:43 AM Get Conduit Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CDT and its competitors with MarketBeat's FREE daily newsletter. Email Address They say it’s ‘unstoppable’ – How I made 43,509% (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss. Click here now for the full story. CDT Media Mentions By Week CDT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDT News Sentiment▼1.000.32▲Average Medical News Sentiment CDT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDT Articles This Week▼11▲CDT Articles Average Week Get Conduit Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CDT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Nektar Therapeutics News Aldeyra Therapeutics News Ovid Therapeutics News 23andMe News Design Therapeutics News 2seventy bio News Acrivon Therapeutics News AC Immune News Foghorn Therapeutics News G1 Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
